openPR Logo
Press release

Respiratory Syncytial Virus Attachment Glycoprotein Market Value Projected to Expand by 2029

02-15-2023 07:52 AM CET | Health & Medicine

Press release from: Orion Market Research

Respiratory Syncytial Virus Attachment Glycoprotein Market

The global respiratory syncytial virus attachment glycoprotein market is anticipated to grow at a significant CAGR during the forecast period. Respiratory syncytial virus or RSV is a common respiratory virus. It usually causes mild, cold-like symptoms and most people recover in a week or two, however, it is very serious especially for infants and older adults. The major factor accelerating the growth of the market is the increasing prevalence of respiratory syncytial virus (RSV) attachment glycoprotein across the globe. According to the National Institute of Allergy and Infectious Disease (NIH), almost all children become infected with RSV by age 2. Additionally, an estimated 75,000 to 125,000 of them are hospitalized each year. Furthermore, it affects an estimated 64 million people with a mortality rate of 160,000 each year. Hence, the rising incidence of the disease is driving the growth of the global respiratory syncytial virus attachment glycoproteins market during the forecast period.

Some major players operating in the market include Bavarian Nordic A/S, Sanofi S.A., and F. Hoffmann-La Roche Ltd., among others. The market players are contributing significantly to the growth of the market by the adoption of various strategies including mergers & acquisitions, geographical expansion, partnerships and collaborations, and new product launches, to stay competitive in the market. For instance, in June 2021, Sanofi announced Nirsevimab being developed in partnership with AstraZeneca. It is the first investigational extended half-life monoclonal antibody (mAb) that aims to protect all infants who enter the first RSV season when they are at the highest risk for severe RSV disease.

To Request a Sample of our Report on Respiratory Syncytial Virus Attachment Glycoprotein Market: https://www.omrglobal.com/request-sample/respiratory-syncytial-virus-attachment-glycoprotein-market

Market Coverage

• The market number available for - 2021-2029

• Base year- 2021

• Forecast period- 2023-2029

Segment Covered-

· By Type

· By Application

Regions Covered-

· North America

· Europe

· Asia-Pacific

· Rest of the World

Competitive Landscape- Bavarian Nordic A/S, Sanofi S.A., and F. Hoffmann-La Roche Ltd., among others.

Respiratory Syncytial Virus Attachment Glycoprotein Market Report by Segment



By Type

• VIS-RSV

• TRL-3D3

• AX-14

• MVA-RSV

• Others



By Application

• Clinics

• Hospitals

• Others

A full Report of Respiratory Syncytial Virus Attachment Glycoprotein Market is Available @ https://www.omrglobal.com/industry-reports/respiratory-syncytial-virus-attachment-glycoprotein-market

Respiratory Syncytial Virus Attachment Glycoprotein Market Report by Region



North America

· United States

· Canada

Europe

· UK

· Germany

· Spain

· France

· Italy

· Rest of Europe

Asia-Pacific

· India

· China

· Japan

· South Korea

· Rest of APAC

Rest of the World

· Latin America

· Middle East & Africa

Reasons to buy from us -

1. We cover more than 15 major industries, further segmented into more than 90 sectors.

2. More than 120 countries are for analysis.

3. Over 100+ paid data sources mined for investigation.

4. Our expert research analysts answer all your questions before and after purchasing your report.

https://www.asiatimeskorea.com/news/2029%eb%85%84%ea%b9%8c%ec%a7%80-%ea%b8%89%ec%86%8d%ed%95%9c-%ec%84%b1%ec%9e%a5%ec%9d%84-%eb%b3%b4%eb%8a%94-%ec%b9%b4%eb%a5%b4%eb%b3%b4%eb%8b%90-%ec%84%a4%ed%8c%8c%ec%9d%b4%eb%93%9c-%ec%8b%9c%ec%9e%a5/330459/
https://monblogapple.com/2023/02/13/le-marche-des-inhibiteurs-du-recepteur-du-facteur-de-croissance-epidermique-devrait-connaitre-une-croissance-considerable-dici-2029/
https://www.diario-ya.com/regionales/%e5%88%b0-2023-%e5%b9%b4%e8%87%b3-2029-%e5%b9%b4%ef%bc%8c%e9%a3%9f%e5%93%81%e8%aa%8d%e8%ad%89%e5%b8%82%e5%a0%b4%e5%b0%87%e5%87%ba%e7%8f%be%e5%bc%b7%e5%8b%81%e5%a2%9e%e9%95%b7/395102/
https://citytoday-hildesheim.de/index.php/2023/02/13/ibeacon-markt-wird-zeuge-einer-wachstumsbeschleunigung-bis-2029/
https://sportmsr.com/%d9%85%d9%86-%d8%a7%d9%84%d9%85%d8%b1%d8%ac%d8%ad-%d8%a3%d9%86-%d9%8a%d8%b4%d9%87%d8%af-%d8%b3%d9%88%d9%82-%d8%a3%d8%ac%d9%87%d8%b2%d8%a9-%d8%a7%d8%b3%d8%aa%d8%b4%d8%b9%d8%a7%d8%b1-%d8%a7%d9%84%d9%82/

Media Contact:

Company Name: Orion Market Research

Contact Person: Mr. Anurag Tiwari

Email: info@omrglobal.com

Contact no: +91 7803040404

About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Respiratory Syncytial Virus Attachment Glycoprotein Market Value Projected to Expand by 2029 here

News-ID: 2930647 • Views:

More Releases from Orion Market Research

Comprehensive Report on Plasminogen Activator Inhibitor Market Growth | 9.2% CAGR to USD 2.5 Billion
Comprehensive Report on Plasminogen Activator Inhibitor Market Growth | 9.2% CAG …
The global Plasminogen Activator Inhibitor Market was valued at approximately USD 220 million in 2024 and is projected to reach around USD 380 million by 2033, growing at a compound annual growth rate (CAGR) of about 6.4% from 2025 to 2033. Request a sample copy of this report at: https://www.omrglobal.com/request-sample/plasminogen-activator-inhibitor-market Plasminogen Activator Inhibitor Market Overview: The Plasminogen Activator Inhibitor (PAI) Market is experiencing steady growth due to its critical role in regulating fibrinolysis
Paricalcitol Market to Reach USD 750 Million by 2033 | CAGR 6.5% (2025-2033)
Paricalcitol Market to Reach USD 750 Million by 2033 | CAGR 6.5% (2025-2033)
The global Paricalcitol Market was valued at approximately USD 450 million in 2024 and is projected to reach around USD 780 million by 2033, growing at a compound annual growth rate (CAGR) of about 6.3% from 2025 to 2033. Request a sample copy of this report at: https://www.omrglobal.com/request-sample/paricalcitol-market Paricalcitol Market Overview: The Paricalcitol Market is witnessing steady growth due to the increasing prevalence of chronic kidney disease (CKD) and secondary hyperparathyroidism worldwide. Paricalcitol,
API intermediate Market Size Analysis, Competitive Insights, Leading Players and Growth Opportunities by 2033
API intermediate Market Size Analysis, Competitive Insights, Leading Players and …
In 2024, the market was valued at approximately USD 45.2 billion and is projected to reach around USD 78.1 billion by 2033, reflecting a compound annual growth rate (CAGR) of 7.6% from 2026 to 2033. API intermediate Market Overview API intermediates are crucial components in the synthesis of active pharmaceutical ingredients, serving as building blocks in the production of various medications. The market's growth is fueled by factors such as the rising
Dialysate Market Insights: Growing at 6.04% CAGR to USD 9.8 Billion by 2031
Dialysate Market Insights: Growing at 6.04% CAGR to USD 9.8 Billion by 2031
The global Dialysate Market was valued at approximately USD 2.8 billion in 2024 and is expected to reach around USD 4.5 billion by 2033, growing at a compound annual growth rate (CAGR) of about 5.7% from 2025 to 2033. Request a sample copy of this report at: https://www.omrglobal.com/request-sample/dialysate-market Dialysate Market Overview: The Dialysate Market is experiencing steady growth driven by the rising prevalence of chronic kidney disease (CKD) and end-stage renal disease (ESRD)

All 5 Releases


More Releases for Respiratory

Global Respiratory Devices and Equipment (Therapeutic) Market | Global Respirato …
The respiratory devices & equipment therapeutic market comprises of the sales of respiratory devices & equipment used for treating the patients with acute or chronic respiratory disorders for instance chronic obstructive pulmonary disease (COPD), sleep disorders, chronic bronchitis, asthma, etc. The market includes sales of respiratory monitoring devices establishments mainly engaged in the manufacturing of oxygen concentrators, nebulizers, humidifiers, positive airway pressure devices, ventilators, capnographs, and gas analyzers. According to study,
Global Respiratory Monitoring Devices Market | Global Respiratory Monitoring Dev …
Respiration is a unique process of human lives, which jumps at the time of birth and lasts till decease. A healthy human body is skilled of respiration process for numerous years but, due to rising levels of pollution in urban cities and lives concerning tobacco smoking, clogging of airways and other structures of the lung is turning into a common concern across the globe. The respiratory monitoring devices market comprises
Middle East and Africa Respiratory InhalerMarket- AstraZeneca is advancing clini …
Recent Developments AstraZeneca is multinational pharmaceutical and Biopharmaceutical Company. The company provides innovative medicines which are used by millions of people worldwide. AstraZeneca reduces the risk of death and disease progression. The company primarily focuses on development and discovery of cardiovascular, respiratory and inflammation, oncology and infectious disease. To know more:https://www.marketdataforecast.com/market-reports/middle-east-and-africa-respiratory-inhaler-market-6377/ Market Segmentations: Market Data Forecast published a report named Middle East and Africa Respiratory InhalerMarket. It is estimated to grow at a robust
Respiratory Devices Analysis Report of Respiratory Devices in Global Market 2018 …
- Global Respiratory Devices Market: Overview Respiratory devices are medical equipment that assist patients with respiration in a critical care situation. Additionally, respiratory devices are used to deliver medicines to treat several respiratory diseases. Moreover, these devices are used to diagnose respiratory problems in patients. Increase in incidence of COPD and sleep apnea, strategic alliance between key players, and rise in government expenditure are the major factors projected to propel the
Neonatal Respiratory Distress Syndrome Market is driven by high prevalence of re …
Neonatal respiratory distress syndrome, also referred to as infant respiratory distress syndrome is characterized by a particular condition often observed in premature babies, usually born about six weeks before their due dates. During this condition, lungs of the premature infants lose the ability to produce enough surfactants in order to provide oxygen to the body. Surfactants are liquids made up of fat and proteins and it helps the lungs to
Global Respiratory Monitoring Devices Market to Benefit from Increasing Prevalen …
Respiratory disease is a serious public health concern due to rapidly growing number of smokers worldwide. Governments are implementing various health schemes to reduce the death rate caused due to respiratory disease and disorders. Respiratory disease is a medical condition that affects the structure and organs (respiratory system) associated with respiration or breathing. Rise in respiratory diseases such as chronic obstructive pulmonary diseases, asthma, and lung cancer has triggered the growth